Invesco Ltd. - ANTARES PHARMA INC ownership

ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 103 filers reported holding ANTARES PHARMA INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of ANTARES PHARMA INC
ValueSharesWeighting
Q1 2022$993,000
+0.3%
242,191
-12.7%
0.00%
Q4 2021$990,000
-3.4%
277,269
-1.6%
0.00%
Q3 2021$1,025,000
-6.2%
281,717
+12.4%
0.00%
Q2 2021$1,093,000
+9.4%
250,691
+3.2%
0.00%
Q1 2021$999,000
+4.0%
243,033
+0.9%
0.00%
Q4 2020$961,000
+35.7%
240,831
-8.2%
0.00%
Q3 2020$708,000
-11.8%
262,352
-10.1%
0.00%
Q2 2020$803,000
+1.9%
291,890
-12.5%
0.00%
Q1 2020$788,000
-27.0%
333,739
+45.2%
0.00%
Q4 2019$1,080,000
+5.2%
229,835
-25.1%
0.00%
Q3 2019$1,027,000
-11.2%
307,034
-12.6%
0.00%
Q2 2019$1,156,000
-12.8%
351,440
-19.6%
0.00%
Q1 2019$1,325,000
+15.6%
437,163
+3.8%
0.00%
Q4 2018$1,146,000
-30.0%
421,208
-13.5%
0.00%
-100.0%
Q3 2018$1,636,000
+15.8%
486,998
-11.1%
0.00%
Q2 2018$1,413,000
+1030.4%
547,851
+868.0%
0.00%
Q1 2018$125,000
+21.4%
56,599
+9.4%
0.00%
Q4 2017$103,000
-36.4%
51,758
+3.7%
0.00%
Q3 2017$162,000
+5.9%
49,914
+4.9%
0.00%
Q2 2017$153,000
+350.0%
47,561
+20.7%
0.00%
Q1 2016$34,000
-33.3%
39,395
-7.4%
0.00%
Q4 2015$51,000
-26.1%
42,557
+4.3%
0.00%
Q3 2015$69,000
-21.6%
40,794
-3.3%
0.00%
Q2 2015$88,000
-92.9%
42,184
-84.8%
0.00%
Q4 2013$1,238,000
+10.0%
277,0000.0%0.00%
Q3 2013$1,125,000
-2.3%
277,0000.0%0.00%
-100.0%
Q2 2013$1,152,000277,0000.00%
Other shareholders
ANTARES PHARMA INC shareholders Q3 2017
NameSharesValueWeighting ↓
WILLIAM HARRIS INVESTORS INC 2,338,735$6,244,0001.73%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 9,603,703$25,642,0001.03%
Broadfin Capital, LLC 6,100,000$16,288,0000.80%
ASHFORD CAPITAL MANAGEMENT INC 1,088,675$2,907,0000.58%
MARINER INVESTMENT GROUP LLC 296,477$792,0000.15%
THOMPSON DAVIS & CO., INC. 36,500$97,0000.14%
Peregrine Asset Advisers, Inc. 53,034$142,0000.13%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,165,738$3,101,0000.12%
Avenir Corp 341,035$911,0000.08%
Brown Advisory Securities, LLC 50,550$135,0000.05%
View complete list of ANTARES PHARMA INC shareholders